ConductScience.org, home

Paper27366142

Recent developments on potential new applications of emetine as anti-cancer agent.

Uzor PF. EXCLI J, 2016. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Recent developments on potential new applications of emetine as anti-cancer agent. Papers, record 27366142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27366142

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent developments on potential new applications of emetine as anti-cancer agent.
PubMed
Journal
EXCLI J
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2024-03-25
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uzor PFPhilip F

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14929936Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.Cancer1971https://conductscience.org/library/papers/4929936PubMed
224747809Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia.Eur J Pharm Biopharm2014https://conductscience.org/library/papers/24747809PubMed
324045224Emetine dihydrochloride: a novel therapy for bladder cancer.J Urol2014https://conductscience.org/library/papers/24045224PubMed
424213797Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.Oncol Rep2014https://conductscience.org/library/papers/24213797PubMed
525310746The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL.Int J Oncol2015https://conductscience.org/library/papers/25310746PubMed
65272222Chemotherapy of neoplasia (cancer) with dehydroemetine.J Trop Med Hyg1969https://conductscience.org/library/papers/5272222PubMed
726278973Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy.Comput Biol Chem2016https://conductscience.org/library/papers/26278973PubMed
920061395Three new O-methyltransferases are sufficient for all O-methylation reactions of ipecac alkaloid biosynthesis in root culture of Psychotria ipecacuanha.J Biol Chem2010https://conductscience.org/library/papers/20061395PubMed
104160874Dehydroemetine in chronic leukaemia.Lancet1966https://conductscience.org/library/papers/4160874PubMed
1221228475Molecular cloning of an O-methyltransferase from adventitious roots of Carapichea ipecacuanha.Biosci Biotechnol Biochem2011https://conductscience.org/library/papers/21228475PubMed
1326798435Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives.World J Gastrointest Oncol2016https://conductscience.org/library/papers/26798435PubMed
144705155A phase I study of emetine hydrochloride (NSC 33669) in solid tumors.Cancer1973https://conductscience.org/library/papers/4705155PubMed
1522988474Alkaloids isolated from natural herbs as the anticancer agents.Evid Based Complement Alternat Med2012https://conductscience.org/library/papers/22988474PubMed
16890691Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents.Cancer Treat Rep1977https://conductscience.org/library/papers/890691PubMed
1712804695Natural products for cancer prevention: a global perspective.Pharmacol Ther2003https://conductscience.org/library/papers/12804695PubMed
1820813864Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma.Mol Pharmacol2010https://conductscience.org/library/papers/20813864PubMed
1926332055Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways.Chem Biol Interact2015https://conductscience.org/library/papers/26332055PubMed
204299101Inhibitors of protein biosynthesis. V. Effects of emetine on protein and nucleic acid biosynthesis in HeLa cells.J Biol Chem1968https://conductscience.org/library/papers/4299101PubMed
2126835873Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.Prostate2016https://conductscience.org/library/papers/26835873PubMed
2222848307Emetine regulates the alternative splicing of caspase 9 in tumor cells.Oncol Lett2011https://conductscience.org/library/papers/22848307PubMed

See all 31 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42634207Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights.J Cell Mol Med2026https://conductscience.org/library/papers/42634207PubMed
42337289Emetine dihydrochloride suppresses the invasiveness and motility of hepatocellular carcinoma cells through MAPK pathway inhibition and Twist1 protein destabilization.Sci Rep2026https://conductscience.org/library/papers/42337289PubMed
38187064Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NFκB and histone deacetylation inhibition.Am J Cancer Res2023https://conductscience.org/library/papers/38187064PubMed
37081916Phytochemical composition and antioxidant activities of some wild edible plants locally consumed by rural communities in northern Uganda.Front Nutr2023https://conductscience.org/library/papers/37081916PubMed
36941385Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways.Cancer Chemother Pharmacol2023https://conductscience.org/library/papers/36941385PubMed
35626133A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma.Cancers (Basel)2022https://conductscience.org/library/papers/35626133PubMed
35187519Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment.Cell Genom2022https://conductscience.org/library/papers/35187519PubMed
33261173Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33261173PubMed
31964796Lead Optimization of Dehydroemetine for Repositioned Use in Malaria.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/31964796PubMed
31436297Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β‑catenin signaling.Oncol Rep2019https://conductscience.org/library/papers/31436297PubMed
29333136Highlight report: The relationship of DNA copy number alterations and mRNA levels in cancer.EXCLI J2017https://conductscience.org/library/papers/29333136PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27366142

GET https://conductscience.org/api/papers/v1/27366142/references?page=2